Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Disruption of homeostatic microRNA (miRNA) expression levels is known to cause human neuropathology. However, the gene regulatory and phenotypic effects of altering a miRNA’s in vivo abundance (rather than its binary gain or loss) are not well understood. By genetic combination, we generated an allelic series of mice expressing varying levels of miR-218, a motor neuron-selective gene regulator associated with motor neuron disease. Titration of miR-218 cellular dose unexpectedly revealed complex, non-ratiometric target mRNA dose responses and distinct gene network outputs. A non-linearly responsive regulon exhibited a steep miR-218 dose-dependent threshold in repression that, when crossed, resulted in severe motor neuron synaptic failure and death. This work demonstrates that a miRNA can govern distinct gene network outputs at different expression levels and that miRNA-dependent phenotypes emerge at particular dose ranges because of hidden regulatory inflection points of their underlying gene networks.
[Display omitted]
•miRNA cellular dose is a major determinant of in vivo neuronal mRNA target selection•Modulation of miR-218 levels reveals distinct dose-response curves of target mRNAs•Motor failure occurs at the miR-218 dose inflection point for an exponential regulon•Motor neuron subtypes are distinguished by magnitude of miR-218-mediated effects
By genetically titrating the levels of the ALS-associated miR-218 in mice, Amin et al. reveal an in vivo inflection point in target mRNA repression that underlies a phenotypic threshold for neuromotor defects and survival.